109 related articles for article (PubMed ID: 11857340)
1. Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.
Hall FC; Rabinowitz JD; Busch R; Visconti KC; Belmares M; Patil NS; Cope AP; Patel S; McConnell HM; Mellins ED; Sonderstrup G
Eur J Immunol; 2002 Mar; 32(3):662-70. PubMed ID: 11857340
[TBL] [Abstract][Full Text] [Related]
2. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles.
Cope AP; Patel SD; Hall F; Congia M; Hubers HA; Verheijden GF; Boots AM; Menon R; Trucco M; Rijnders AW; Sønderstrup G
Arthritis Rheum; 1999 Jul; 42(7):1497-507. PubMed ID: 10403279
[TBL] [Abstract][Full Text] [Related]
3. Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation.
Boots AM; Hubers H; Kouwijzer M; den Hoed-van Zandbrink L; Westrek-Esselink BM; van Doorn C; Stenger R; Bos ES; van Lierop MJ; Verheijden GF; Timmers CM; van Staveren CJ
Arthritis Res Ther; 2007; 9(4):R71. PubMed ID: 17645792
[TBL] [Abstract][Full Text] [Related]
4. Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells.
Patil NS; Hall FC; Drover S; Spurrell DR; Bos E; Cope AP; Sonderstrup G; Mellins ED
J Immunol; 2001 Jan; 166(1):33-41. PubMed ID: 11123274
[TBL] [Abstract][Full Text] [Related]
5. Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.
van Lierop MJ; den Hoed L; Houbiers J; Vencovsky J; Ruzickova S; Krystufkova O; van Schaardenburg M; van den Hoogen F; Vandooren B; Baeten D; De Keyser F; Sønderstrup G; Bos E; Boots AM
Arthritis Rheum; 2007 Jul; 56(7):2150-9. PubMed ID: 17599744
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
7. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
[TBL] [Abstract][Full Text] [Related]
8. pH stability of HLA-DR4 complexes with antigenic peptides.
Belmares MP; Rabinowitz JD; Liu W; Mellins ED; McConnell HM
Biochemistry; 2000 Nov; 39(47):14558-66. PubMed ID: 11087411
[TBL] [Abstract][Full Text] [Related]
9. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.
Belmares MP; Busch R; Mellins ED; McConnell HM
Biochemistry; 2003 Jan; 42(3):838-47. PubMed ID: 12534297
[TBL] [Abstract][Full Text] [Related]
10. Identification of autoantigen epitopes in MHC class II transgenic mice.
Sønderstrup G; McDevitt H
Immunol Rev; 1998 Aug; 164():129-38. PubMed ID: 9795771
[TBL] [Abstract][Full Text] [Related]
11. Crystallization of HLA-DR4 fused to an immunodominant collagen II peptide implicated in rheumatoid arthritis.
Hurlbert JC; Izard T
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 1):1749-51. PubMed ID: 12351899
[TBL] [Abstract][Full Text] [Related]
12. Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages.
Tsark EC; Wang W; Teng YC; Arkfeld D; Dodge GR; Kovats S
J Immunol; 2002 Dec; 169(11):6625-33. PubMed ID: 12444176
[TBL] [Abstract][Full Text] [Related]
13. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice.
Patel SD; Cope AP; Congia M; Chen TT; Kim E; Fugger L; Wherrett D; Sonderstrup-McDevitt G
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8082-7. PubMed ID: 9223318
[TBL] [Abstract][Full Text] [Related]
14. Functional HLA-DM on the surface of B cells and immature dendritic cells.
Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
[TBL] [Abstract][Full Text] [Related]
15. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.
Andersson EC; Hansen BE; Jacobsen H; Madsen LS; Andersen CB; Engberg J; Rothbard JB; McDevitt GS; Malmström V; Holmdahl R; Svejgaard A; Fugger L
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7574-9. PubMed ID: 9636191
[TBL] [Abstract][Full Text] [Related]
16. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
[TBL] [Abstract][Full Text] [Related]
17. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.
Amria S; Hajiaghamohseni LM; Harbeson C; Zhao D; Goldstein O; Blum JS; Haque A
Eur J Immunol; 2008 Jul; 38(7):1961-70. PubMed ID: 18506881
[TBL] [Abstract][Full Text] [Related]
18. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin.
Congia M; Patel S; Cope AP; De Virgiliis S; Sønderstrup G
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3833-8. PubMed ID: 9520453
[TBL] [Abstract][Full Text] [Related]
19. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.
Haque MA; Hawes JW; Blum JS
J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711
[TBL] [Abstract][Full Text] [Related]
20. Cytokines elicited by T cell epitopes from a synovial autoantigen: altered peptide ligands can reduce interferon-gamma and interleukin-10 production.
Hall FC; Visconti KC; Ahmad RC; Parry SL; Miltenburg AM; McConnell HM; Mellins ED; Sønderstrup G
Arthritis Rheum; 2003 Aug; 48(8):2375-85. PubMed ID: 12905493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
